Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients

Minerva Med. 2018 Aug;109(4):337-340. doi: 10.23736/S0026-4806.18.05287-4. Epub 2018 Feb 19.
No abstract available

MeSH terms

  • Aged
  • Cancer Pain / drug therapy*
  • Delayed-Action Preparations / therapeutic use
  • Drug Combinations
  • ErbB Receptors / genetics
  • Female
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / genetics
  • Male
  • Naloxone / therapeutic use*
  • Oxycodone / therapeutic use*
  • Pain Management / methods*
  • Retrospective Studies

Substances

  • Delayed-Action Preparations
  • Drug Combinations
  • oxycodone naloxone combination
  • Naloxone
  • Oxycodone
  • ErbB Receptors